FDA
approval
· 2025-07-24
FDA Approved: SDAMLO — Original Application (Pangea Pharmaceuticals, LLC)
Summary
The FDA approved SDAMLO (amlodipine) under an Original Application (NDA 219531) by Pangea Pharmaceuticals, LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for SDAMLO (AMLODIPINE)